Cargando…
Targeting neddylation E2s: a novel therapeutic strategy in cancer
Ubiquitin-conjugating enzyme E2 M (UBE2M) and ubiquitin-conjugating enzyme E2 F (UBE2F) are the two NEDD8-conjugating enzymes of the neddylation pathway that take part in posttranslational modification and change the activity of target proteins. The activity of E2 enzymes requires both a 26-residue...
Autores principales: | Zheng, Yi-Chao, Guo, Yan-Jia, Wang, Bo, Wang, Chong, Mamun, M. A. A., Gao, Ya, Liu, Hong-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028724/ https://www.ncbi.nlm.nih.gov/pubmed/33827629 http://dx.doi.org/10.1186/s13045-021-01070-w |
Ejemplares similares
-
Discovery of neddylation E2s inhibitors with therapeutic activity
por: Mamun, MAA, et al.
Publicado: (2023) -
Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity
por: Jones, Trace M., et al.
Publicado: (2023) -
Targeting cullin neddylation for cancer and fibrotic diseases
por: He, Zhang-Xu, et al.
Publicado: (2023) -
Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target
por: Gao, Qiang, et al.
Publicado: (2014) -
Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer
por: Chen, Ping, et al.
Publicado: (2015)